Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data
Generic Name : Trametinib
Indication : As monotherapy or in combination w/ dabrafenib for the treatment of adult patients w/ unresectable or metastatic melanoma w/ BRAF V600 mutation. In combination w/ dabrafenib for the adjuvant treatment...
Manufacturer : Novartis
Distributor : Four Star / Zuellig
Generic Name : Bevacizumab
Indication : Treatment of adult patients w/ metastatic carcinoma of the colon or rectum, in combination w/ fluoropyrimidine-based chemotherapy. 1st-line treatment of adult patients w/ metastatic breast cancer, in ...
Manufacturer : Amgen
Distributor : Zuellig
Generic Name : Sorafenib
Indication : Treatment of hepatocellular carcinoma (HCC). Treatment of patients w/ advanced renal cell carcinoma (RCC) who have failed prior interferon-α or interleukin-2 based therapy or are considered unsu...
Manufacturer : Bayer
Generic Name : Ixazomib
Indication : In combination w/ lenalidomide & dexamethasone for the treatment of multiple myeloma.
Manufacturer : Takeda
Generic Name : Enfortumab vedotin
Indication : Monotherapy for locally advanced or metastatic urothelial cancer in adults who have previously received a platinum-containing chemotherapy & a programmed death receptor-1 or programmed death-ligan...
Manufacturer : Baxter Oncology
Marketer : Astellas

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in